Boston Scientific said on Tuesday it will buy Silk Road Medical, a medical device company treating stroke, for $1.16 billion.
Silk Road Medical sells technology meant to prevent stroke in patients with carotid artery disease, a condition creating blockages in the major blood vessels connected to the brain. The company’s core products enable a procedure that temporarily sends blood flow away from the brain to prevent plaque from blocking the vessel. Doctors then implant a stent to widen the artery.
Silk Road Medical’s devices are the only commercially available products for this specific procedure, called transcarotid artery revascularization. The technology earned Food and Drug Administration approval in 2015. Other big players in the vascular device world are LeMaitre Vascular and Baxter.
Click this link for the original source of this article.
Author: Lizzy Lawrence
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.